Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00024557
Status:
COMPLETED
Last Update Posted:
2011-06-06
First Post:
2001-09-20
Brief Title:
Histologic EffectSafety of PrePost-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Sponsor:
INSYS Therapeutics Inc
Organization:
INSYS Therapeutics Inc
Organization Data
Organization:
INSYS Therapeutics Inc
Class:
INDUSTRY
Study ID:
IL13PEI-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
INSYS Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None